Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells

<div>Schematic of TPX2 roles in prostate cancer progression. TPX2 enhanced the transcription factor activation of AR (a), inhibiting TPX2 is a potential therapeutic target against prostate cancer progression via AR signaling suppression (b).</div>

Journal of Oncology

fig8

Figure 8

Figure 8: Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells 